Vacca, A.Meune, C.Gordon, J.Chung, L.Proudman, S.Assassi, S.Nikpour, M.Rodriguez-Reyna, T.Khanna, D.Lafyatis, R.Matucci-Cerinic, M.Distler, O.Allanore, Y.2014-12-172014-12-172014Rheumatology, 2014; 53(7):1172-11771462-03241462-0332http://hdl.handle.net/2440/88211Signs and symptoms of arrhythmias or conduction defects are frequently reported in patients with SSc. These rhythm disorders may have several origins (i.e. related to primary heart involvement, pericardial disease, valvular regurgitation or pulmonary arterial hypertension) and may negatively affect the overall prognosis of these patients. It is therefore important to identify patients at high risk for cardiac arrhythmias with a complete cardiological evaluation and to identify the underlying heart disease, including SSc-related myocardial involvement. In addition, some therapeutic options in SSc patients may differ from those recommended in other populations.en© The Author 2013. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.Systemic sclerosis; arrhythmias; conduction defects; cardiac involvement; mortalityJournal article002013813010.1093/rheumatology/ket3770003386470000042-s2.0-8490299375714475Proudman, S. [0000-0002-3046-9884]